Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 2/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1221745 | 0.94 | ALDH1A1 (0.33) | PIK3CAMAPTRECQLCNR2ALDH1A1 | |
| SCHEMBL14749234 | 0.86 | PIK3CD (0.33) | BRD4PIK3CDPIK3CAPIK3CBMAPT | |
| SCHEMBL13512867 | 0.86 | SLC2A1 (0.34) | PIK3CDPIK3CAPIK3CBMAPTRECQL | |
| SCHEMBL12894432 | 0.83 | CASP1 (0.32) | PIK3CAMAPTRECQLALDH1A1 | |
| SCHEMBL1222136 | 0.82 | ALDH1A1 (0.35) | BRD4PIK3CAMAPTRECQLALDH1A1 | |
| SCHEMBL14749236 | 0.81 | CNR1 (0.34) | BRD4PIK3CDPIK3CAPIK3CBMAPT | |
| SCHEMBL1222176 | 0.80 | CYP1A2 (0.35) | PIK3CAMAPTRECQLALDH1A1 | |
| SCHEMBL12881003 | 0.79 | ALDH1A1 (0.34) | PIK3CAMAPTRECQLALDH1A1 | |
| SCHEMBL1222177 | 0.79 | CASP1 (0.35) | PIK3CDPIK3CAPIK3CBRECQLCNR2 | |
| Hydrochloric Acid SCHEMBL1221826 | 0.79 | ALDH1A1 (0.34) | PIK3CAMAPTRECQLALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130059865-A1 | COMPOUNDS HAVING ANTIVIRAL PROPERTIES | AVEXA LIMITED (AU) | 2013-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059865-A1 | COMPOUNDS HAVING ANTIVIRAL PROPERTIES | ZC3HAV1, ACE, EIF2AK2 | BRD4 3765/4885PIK3CD 2091/4885PIK3CA 1718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.